DEXMETHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE 5 mg Capsule, Extended Release
Also known as Dexmethylphenidate Hydrochloride. Coverage in Delaware, DC and Maryland (CMS PDP Region 05).
1 of 10 stand-alone Part D plans in Delaware, DC and Maryland cover this drug on tier 4.
No plan applies a prior authorization, step therapy or quantity limit.
51 Medicare Advantage plans in DE, DC, MD do cover it
Medicare Advantage plans carry their own formularies, separate from stand-alone Part D. A patient on an MA-PD plan may have coverage even where no PDP lists the drug. DE: 21 plans · DC: 10 plans · MD: 20 plans.
Every plan that covers it
| Plan | Tier | 30-day preferred | 90-day mail | Unit cost | Est. 30-day fill | Restrictions |
|---|---|---|---|---|---|---|
| AARP Medicare Rx Preferred from UHC (PDP)$94.50/mo premium · $130.00 deductible | 4Non-Preferred Drug | 34% | — | $1.4420 | — | None |
Cost-sharing is the initial coverage phase at a preferred pharmacy; a percentage is coinsurance of the plan’s negotiated price, and the deductible may apply first. CMS publishes a negotiated price per unit, so the 30-day fill is shown only where the plan’s own quantity limit supplies the quantity.